Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Gert U van Zyl"'
Autor:
Seth C Inzaule, Mark J Siedner, Susan J Little, Santiago Avila-Rios, Alisen Ayitewala, Ronald J Bosch, Vincent Calvez, Francesca Ceccherini-Silberstein, Charlotte Charpentier, Diane Descamps, Susan H Eshleman, Joseph Fokam, Lisa M Frenkel, Ravindra K Gupta, John P A Ioannidis, Pontiano Kaleebu, Rami Kantor, Seble G Kassaye, Sergei L Kosakovsky Pond, Vinie Kouamou, Roger D Kouyos, Daniel R Kuritzkes, Richard Lessells, Anne-Genevieve Marcelin, Lawrence Mbuagbaw, Brian Minalga, Nicaise Ndembi, Richard A Neher, Roger Paredes, Deenan Pillay, Elliot G Raizes, Soo-Yon Rhee, Douglas D Richman, Kiat Ruxrungtham, Pardis C Sabeti, Jonathan M Schapiro, Sunee Sirivichayakul, Kim Steegen, Wataru Sugiura, Gert U van Zyl, Anne-Mieke Vandamme, Annemarie M J Wensing, Joel O Wertheim, Huldrych F Gunthard, Michael R Jordan, Robert W Shafer
Publikováno v:
PLoS Medicine, Vol 20, Iss 9, p e1004293 (2023)
• Human immunodeficiency virus (HIV) drug resistance has implications for antiretroviral treatment strategies and for containing the HIV pandemic because the development of HIV drug resistance leads to the requirement for antiretroviral drugs that
Externí odkaz:
https://doaj.org/article/c16a34440b374c53938659e86b679144
Autor:
Michael A Linström, Wolfgang Preiser, Nokwazi N Nkosi, Helena W Vreede, Stephen N J Korsman, Annalise E Zemlin, Gert U van Zyl
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245189 (2021)
Automated testing of HIV serology on clinical chemistry analysers has become common. High sample throughput, high HIV prevalence and instrument design could all contribute to sample cross-contamination by microscopic droplet carry-over from seroposit
Externí odkaz:
https://doaj.org/article/ebf4f8b43546469c9ab15e605df7a616
Autor:
Soo-Yon Rhee, Michael R Jordan, Elliot Raizes, Arlene Chua, Neil Parkin, Rami Kantor, Gert U Van Zyl, Irene Mukui, Mina C Hosseinipour, Lisa M Frenkel, Nicaise Ndembi, Raph L Hamers, Tobias F Rinke de Wit, Carole L Wallis, Ravindra K Gupta, Joseph Fokam, Clement Zeh, Jonathan M Schapiro, Sergio Carmona, David Katzenstein, Michele Tang, Avelin F Aghokeng, Tulio De Oliveira, Annemarie M J Wensing, Joel E Gallant, Mark A Wainberg, Douglas D Richman, Joseph E Fitzgibbon, Marco Schito, Silvia Bertagnolio, Chunfu Yang, Robert W Shafer
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145772 (2015)
The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing
Externí odkaz:
https://doaj.org/article/7187aebbffbc469893ba57022e00b398
Autor:
Gert U Van Zyl, Tommy F Liu, Mathilda Claassen, Susan Engelbrecht, Tulio de Oliveira, Wolfgang Preiser, Natasha T Wood, Simon Travers, Robert W Shafer
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e67188 (2013)
OBJECTIVESSouth Africa's national antiretroviral (ARV) treatment program expanded in 2010 to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for adults and abacavir (ABC) for children. We investigated the associate
Externí odkaz:
https://doaj.org/article/74015dd0882a41f9a24cdfaeb1228095
Publikováno v:
Southern African Journal of HIV Medicine, Vol 23, Iss 1, Pp e1-e4 (2022)
No abstract available.
Externí odkaz:
https://doaj.org/article/700b300529d148788f009a830673db64
Autor:
Tracy Kellermann, Monica Gandhi, Eric H Decloedt, Gert U. van Zyl, Matthew A Spinelli, Zukiswa Nkantsu, Marije van Schalkwyk, Dolphina Cogill, Catherine Orrell, Lauren Jennings
Publikováno v:
AIDS Res Hum Retroviruses
Introduction The high cost of viral load (VL) testing limits its use for antiretroviral treatment (ART) adherence support. A low-cost lateral flow urine tenofovir (TFV) rapid assay predicts PrEP breakthroughs but has not yet been investigated in HIV
Autor:
Barbara Laughton, Shalena Naidoo, Els F.M.T. Dobbels, Michael J. Boivin, Anita Janse van Rensburg, Richard H. Glashoff, Gert U. van Zyl, Mariana Kruger, Mark F. Cotton
Publikováno v:
Southern African Journal of HIV Medicine, Vol 20, Iss 1, Pp e1-e8 (2019)
Background: Antiretroviral therapy (ART) started between 7 and 12 weeks of age improves neurodevelopmental outcomes in HIV-infected (HIV+) infants, but the impact of even earlier initiation is not yet described. Objective: We assessed the early neur
Externí odkaz:
https://doaj.org/article/2fb1e1b3b6774a87a16d1e72a061c921
Autor:
Pierre Goussard, Pawel Schubert, Noor Parker, Chantelle Myburgh, Helena Rabie, Marieke M. van der Zalm, Gert U. Van Zyl, Wolfgang Preiser, Tongai G. Maponga, Janette Verster, Andre G. Gie, Savvas Andronikou
Publikováno v:
Pediatric Pulmonology. 57:1363-1365
Autor:
Kaneez Sayed, Rene Goliath, Claire Keene, Rulan Griesel, Gert U. van Zyl, Eric Goemaere, Olina Ngwenya, Graeme Meintjes, Andrew Hill, Ying Zhao, Tracy Flowers, Tali Cassidy, Lubbe Wiesner, Gary Maartens, Zimasa Gcwabe, Charlotte Schutz, Amanda Jackson, Bryony Simmons
Publikováno v:
AIDS. 35:1423-1432
Objective: Recycling tenofovir and lamivudine/emtricitabine (XTC) with dolutegravir would provide a more tolerable, affordable, and scalable second-line regimen than dolutegravir with an optimized nucleoside reverse transcriptase inhibitor (NRTI) bac
Publikováno v:
Current opinion in HIV and AIDS. 17(4)
HIV drug resistance testing using blood plasma or dried blood spots forms part of international guidelines. However, as the clinical utility of assessing drug resistance in other body compartments is less well established, we review this for blood ce